Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...
My computer coding education ended in a high school classroom in the early 2000s, when I created a game in which two camels spit at one another. The experience of typing every line of code was ...